The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: K3 director linked to purchase, Diurnal exec sells shares into ISA

Mon, 09th May 2022 14:01

(Sharecast News) - Software company K3 Business Technology was at the top of the list of buys on Monday, after Kestrel Partners spent more than £40k on its shares.

The AIM-traded firm said Kestrel Partners, on behalf of its discretionary clients, bought 27,129 shares for 150p each, spending a total of £40,693.50.

Its non-executive director Oliver Scott is a partner of, and holds a beneficial interest in Kestrel, and is also a shareholder in one of Kestrel's clients, Kestrel Opportunities, and so has a beneficial interest in Kestrel Opportunities' entire legal holding in the company.

Following the purchase, K3 said Kestrel Opportunities held 8,515,879 of its shares, and other clients of Kestrel in which Scott had no beneficial interest held 2,775,101 shares.

In total, Kestrel indirectly held voting rights over 11,290,980 of K3's shares, representing 25.24% percent of its issued share capital.

On the selling side of the ledger, specialty pharmaceutical company Diurnal Group disclosed a sale worth over £40k made by its chief scientific officer.

The AIM-traded firm said Richard Ross sold 312,000 shares for 13p each, while his and his wife's individual savings accounts (ISAs) purchased 153,500 and 153,500 shares, respectively, at a price of 13.01p each.

Following the transactions, the total beneficial interest of Richard Ross and his connected parties was 2,257,155 shares, representing 1.33% of Diurnal's total voting rights as of 9 May.

Top Director Buys

K3 Business Technology Group (KBT)

Director name: Scott,Oliver Rupert Andrew

Amount purchased: 27,129 @ 150.00p

Value: £40,693.50

Diurnal Group (DNL)

Director name: Ross,Richard

Amount purchased: 153,500 @ 13.01p

Value: £19,970.35

Diurnal Group (DNL)

Director name: Ross,Richard

Amount purchased: 153,500 @ 13.01p

Value: £19,970.35

Discoverie Group (DSCV)

Director name: Watson ,Clive

Amount purchased: 2,875 @ 690.00p

Value: £19,837.50

Henderson Smaller Companies Inv Trust (HSL)

Director name: Carter,Kevin

Amount purchased: 1,500 @ 868.36p

Value: £13,025.39

Target Healthcare Reit Ltd (THRL)

Director name: Fyfe,Alison

Amount purchased: 10,000 @ 109.80p

Value: £10,980.00

Mgc Pharmaceuticals Limited Npv (di) (MXC)

Director name: Zomer,Roby

Amount purchased: 819,672 @ 1.30p

Value: £10,655.74

Parity Group (PTY)

Director name: Johns,Mike

Amount purchased: 139,082 @ 7.19p

Value: £10,000.00

Mondi (MNDI)

Director name: Strank,Angela

Amount purchased: 628 @ 1,579.95p

Value: £9,922.08

Henderson Smaller Companies Inv Trust (HSL)

Director name: Freer,Penelope Anne

Amount purchased: 1,000 @ 878.92p

Value: £8,789.20

Reach (RCH)

Director name: Panayi,Barry

Amount purchased: 3,979 @ 124.72p

Value: £4,962.77

Capita (CPI)

Director name: Murphy,Joseph

Amount purchased: 643 @ 26.83p

Value: £172.52

Capita (CPI)

Director name: Lewis,Jonathan (Jon)

Amount purchased: 643 @ 26.83p

Value: £172.52

Capita (CPI)

Director name: Weller,Tim

Amount purchased: 643 @ 26.83p

Value: £172.52

Assura (AGR)

Director name: Cottam,Jayne

Amount purchased: 228 @ 66.16p

Value: £150.84

Assura (AGR)

Director name: Murphy,Jonathan

Amount purchased: 228 @ 66.16p

Value: £150.84

Top Director Sells

Rolls-royce Holdings (RR.)

Director name: East,Warren

Amount sold: 210,515 @ 83.78p

Value: £176,369.47

Diurnal Group (DNL)

Director name: Ross,Richard

Amount sold: 312,000 @ 13.00p

Value: £40,560.00

More News
28 Oct 2022 21:18

TRADING UPDATES: SulNOx, Marwyn loss widens; Kropz gets new facility

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
21 Oct 2022 21:29

TRADING UPDATES: Trackwise Designs wins deal; Cake Box names CFO

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
14 Oct 2022 15:48

UK shareholder meetings calendar - next 7 days

Monday 17 October 
Arcontech Group PLCAGM
Barratt Developments PLCAGM
Eight Capital Partners PLCGM re IWEP loan conversion to equity
Tuesday 18 October 
Accrol Group Holdings PLCAGM
Diverse Income TrustAGM
Dolphin Capital Investors LtdAGM
Pantheon International PLCAGM
Tlou Energy LtdAGM
Wednesday 19 October 
Empyrean Energy PLCGM annual report approval
Frasers Group PLCAGM
Hargreaves Lansdown PLCAGM
HydrogenOne Capital Growth PLCGM share issuance programme
Made Tech Group PLCAGM
SME Credit Realisation Fund LtdAGM
Thursday 20 October 
abrdn UK Smaller Companies Growth Trust PLCAGM
Argo Group LtdAGM
Dechra Pharmaceuticals PLCAGM
DX Group PLCGM re 2021 financial year annual report
Gateley Holdings PLCAGM
Science in Sport PLCGM 
Xeros Technology Group PLCGM capital reorganisation
Friday 21 October 
Diurnal Group PLCGM re Neurocrine takeover
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
7 Oct 2022 13:01

Diurnal treatment gets approval from Welsh regulatory body

(Alliance News) - Diurnal Group PLC on Friday said its Efmody treatment has been recommended as an option to treat patients with congenital adrenal hyperplasia.

Read more
7 Oct 2022 11:31

Diurnal's 'Efmody' treatment gets thumbs-up for NHS Wales

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Friday that the All-Wales Medicines Strategy Group (AWMSG) has recommended its 'Efmody' hydrocortisone modified-release hard capsules as an option for restricted use to treat adolescents and adults with congenital adrenal hyperplasia (CAH) within NHS Wales.

Read more
14 Sep 2022 11:40

Diurnal annual loss widens despite revenue growth as costs balloon

(Alliance News) - Diurnal Group PLC on Wednesday reported a widened annual loss as costs, especially on research & development, surged.

Read more
7 Sep 2022 15:53

UK earnings, trading statements calendar - next 7 days

Thursday 8 September 
Arecor Therapeutics PLCHalf Year Results
Cairn Homes PLCHalf Year Results
Chaarat Gold Holdings LtdHalf Year Results
Curtis Banks Group PLCHalf Year Results
Darktrace PLCFull Year Results
Destiny Pharma Holdings PLCHalf Year Results
Duke Royalty LtdFull Year Results
Emis Group PLCHalf Year Results
Energean PLCHalf Year Results
Funding Circle Holdings PLCHalf Year Results
Genus PLCFull Year Results
International Public Partnerships LtdHalf Year Results
Melrose Industries PLCHalf Year Results
Mpac Group PLCHalf Year Results
M Winkworth PLCHalf Year Results
Oakley Capital Investments LtdHalf Year Results
Open Orphan PLCHalf Year Results
Restaurant Group PLCHalf Year Results
Safestore Holdings PLCQ3 Results
Severfield PLCFull Year Results
Shield Therapeutics PLCHalf Year Results
SourceBio International PLCHalf Year Results
Spire Healthcare Group PLCHalf Year Results
Sylvania Platinum LtdFull Year Results
Vistry Group PLCHalf Year Results
Friday 9 September 
Computacenter PLCHalf Year Results
Creo Medical Group PLCHalf Year Results
Mid Wynd International Investment Trust PLCFull Year Results
Monday 12 September 
ABCAM PLCHalf Year Results
Arcontech Group PLCFull Year Results
Associated British Foods PLCFull Year Results
Greencoat Renewables PLCHalf Year Results
HgCapital Trust PLCHalf Year Results
Kape Technologies PLCHalf Year Results
Made Tech Group PLCFull Year Results
MP Evans Group PLCHalf Year Results
SigmaRoc PLCHalf Year Results
Tirupati Graphite PLCFull Year Results
Tuesday 13 September 
accesso Technology Group PLCHalf Year Results
Churchill China PLCHalf Year Results
Corero Network Security PLCHalf Year Results
Engage XR Holdings PLCHalf Year Results
Facilities by ADF PLCHalf Year Results
Fevertree Drinks PLCHalf Year Results
Futura Medical PLCHalf Year Results
Gateley Holdings PLCFull Year Results
Harworth Group PLCHalf Year Results
HeiQ PLCHalf Year Results
JTC PLCHalf Year Results
Mattioli Woods PLCFull Year Results
Ocado Group PLCTrading Statement
Oxford Nanopore Technologies PLCHalf Year Results
Petra Diamonds LtdFull Year Results
Property Franchise Group PLCHalf Year Results
RBG Holdings PLCHalf Year Results
Smart Metering Systems PLCHalf Year Results
Team17 Group PLCHalf Year Results
Trustpilot Group PLCHalf Year Results
VH Global Sustainable Energy Opportunities PLCHalf Year Results
Wednesday 14 September 
Anpario PLCHalf Year Results
Advanced Medical Solutions Group PLCHalf Year Results
BioPharma Credit PLCHalf Year Results
Blackbird PLCHalf Year Results
Central Asia Metals PLCHalf Year Results
Diurnal Group PLCHalf Year Results
Dunelm Group PLCFull Year Results
Epwin Group PLCHalf Year Results
Glenveagh Properties PLCHalf Year Results
ITM Power PLCFull Year Results
Niox Group PLCHalf Year Results
Pan African Resources PLCFull Year Results
Pharos Energy PLCHalf Year Results
Redrow PLCFull Year Results
Ricardo PLCFull Year Results
STM Group PLCHalf Year Results
Artisanal Spirits Co PLCHalf Year Results
Tullow Oil PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
30 Aug 2022 17:04

LONDON MARKET CLOSE: Stocks move into reverse as pessimism takes over

(Alliance News) - Stocks in London returned from the long weekend on Tuesday to close in the red despite spending most of the session in the green, as investors wiped out the morning's gains following selling pressure in the US.

Read more
30 Aug 2022 14:55

Diurnal to be taken over by Neurocrine Biosciences for £48.3m, shares surge

(Sharecast News) - Diurnal shares surged on Tuesday after it agreed to be taken over by US biotech firm Neurocrine Biosciences for £48.3m.

Read more
30 Aug 2022 12:47

Diurnal shares double on GBP48 million takeover from Neurocrine

(Alliance News) - Diurnal Group PLC on Tuesday said it agreed to a GBP48.3 million takeover from US biopharmaceutical firm Neurocrine Biosciences Inc.

Read more
30 Aug 2022 11:04

AIM WINNERS & LOSERS: Diurnal shares more than double on takeover bid

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
26 Jul 2022 12:03

IN BRIEF: Diurnal more than doubles product sales in 2022

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Says product sales in the year ended June 30, more than doubled to GBP4.6 million from GBP2.3 million the previous year. Revenue in the year totals GBP4.7 million including licensing income of GBP600,000, up from GBP4.4 million the previous year, including licensing income of GBP2.1 million.

Read more
1 Jun 2022 19:41

TRADING UPDATES: Indivior, Diurnal start trials; Alien Metals tests

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
25 Apr 2022 19:19

IN BRIEF: Diurnal expands distribution agreement with EffRx

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Extends distribution and marketing agreement with EffRx Pharmaceuticals in Switzerland to include Efmody.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.